As of November 2024, Provectus Biopharmaceuticals has a market cap of $37.76M. This makes Provectus Biopharmaceuticals the world's 26779th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $57.26M | 42.18% |
2023 | $40.27M | -11.11% |
2022 | $45.31M | 96.36% |
2021 | $23.07M | -5.17% |
2020 | $24.33M | -7.94% |
2019 | $26.43M | 26.00% |
2018 | $20.98M | -39.02% |
2017 | $34.40M | 310.00% |
2016 | $8.39M | -94.87% |
2015 | $163.61M | -51.25% |
2014 | $335.62M | -66.80% |
2013 | $1.01B | 330.36% |
2012 | $234.93M | -30.86% |
2011 | $339.81M | -13.83% |
2010 | $394.35M | 3.30% |
2009 | $381.77M | -1.09% |
2008 | $385.96M | -46.51% |
2007 | $721.58M | 44.54% |
2006 | $499.23M | 32.22% |
2005 | $377.57M | 36.36% |
2004 | $276.88M | -34.65% |
2003 | $423.72M | 260.71% |
2002 | $117.47M | -99.96% |
2001 | $264.30B | 20.00% |
2000 | $220.25B | -65.00% |
1999 | $629.28B | 0.00% |
1998 | $629.28B | 0.00% |
1997 | $629.28B | - |